SEC Form 4 · accession 0001225208-15-021070
Cigna Holding Co · CI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Herbert A Fritch
Officer — President, HealthSpring
Period of report
Nov 16, 2015
Accepted (ET)
Nov 18, 2015 · 6:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000701221
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.25 Par Value | Nov 16, 2015 | M | 16,676 | $30.13 | A | 295,989 | D | |
| Common Stock, $.25 Par Value | Nov 16, 2015 | M | 11,778 | $58.73 | A | 307,767 | D | |
| Common Stock, $.25 Par ValueF2 | Nov 16, 2015 | S | 7,647 | $132.2329 | D | 300,120 | D | |
| Common Stock, $.25 Par ValueF3 | Nov 16, 2015 | S | 8,900 | $133.7912 | D | 291,220 | D | |
| Common Stock, $.25 Par ValueF4 | Nov 16, 2015 | S | 23,610 | $133.2572 | D | 267,610 | D | |
| Common Stock, $.25 Par Value | Nov 17, 2015 | M | 4,720 | $30.13 | A | 272,330 | D | |
| Common Stock, $.25 Par Value | Nov 17, 2015 | M | 2,215 | $58.73 | A | 274,545 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F5 | $30.13 | Nov 16, 2015 | M | 16,676 | D | — | Mar 7, 2021 | Common Stock, $.25 Par Value | 16,676 | 76,712 | D |
| Employee Stock Option (Right to Buy)F6 | $58.73 | Nov 16, 2015 | M | 11,778 | D | Mar 5, 2014 | Mar 5, 2023 | Common Stock, $.25 Par Value | 11,778 | 30,191 | D |
| Employee Stock Option (Right to Buy)F5 | $30.13 | Nov 17, 2015 | M | 4,720 | D | — | Mar 7, 2021 | Common Stock, $.25 Par Value | 4,720 | 71,992 | D |
| Employee Stock Option (Right to Buy)F6 | $58.73 | Nov 17, 2015 | M | 2,215 | D | Mar 5, 2014 | Mar 5, 2023 | Common Stock, $.25 Par Value | 2,215 | 27,976 | D |
Explanation of responses
- F1These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2014.
- F2Represents the weighted average price of the shares sold. The prices actually received ranged from $131.59 to $132.56 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F3Represents the weighted average price of the shares sold. The prices actually received ranged from $133.60 to $134.07 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F4Represents the weighted average price of the shares sold. The prices actually received ranged from $132.60 to $133.59 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- F5This option vested as follows: 50% on March 7, 2013, 25% on March 7, 2014 and 25% on March 7, 2015.
- F6This option was granted on March 5, 2013. The option vests in three equal annual installments on the first, second and third anniversaries of the grant date.